100 related articles for article (PubMed ID: 27577260)
1. Impact of metronomic neoadjuvant chemotherapy on early tongue cancer.
Kina S; Nakasone T; Kinjo T; Maruyama T; Kawano T; Arasaki A
Cancer Chemother Pharmacol; 2016 Oct; 78(4):833-40. PubMed ID: 27577260
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after up-front surgery and metronomic neoadjuvant chemotherapy with S-1 or UFT for early tongue squamous cell carcinoma.
Kina S; Nakasone T; Kinjo T; Nimura F; Sunagawa N; Arasaki A
Clin Oral Investig; 2019 Jun; 23(6):2593-2598. PubMed ID: 30317400
[TBL] [Abstract][Full Text] [Related]
3. [Role of induction chemotherapy with bleomycin A5 in treating stage T2 tongue squamous cell carcinoma].
Hua H; Zeng ZY; Xu GP; Chen FJ; Guo ZM; Wu GH; Zhang Q; Yang AK
Ai Zheng; 2002 Dec; 21(12):1372-5. PubMed ID: 12520752
[TBL] [Abstract][Full Text] [Related]
4. A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.
Kina S; Kawabata-Iwakawa R; Miyamoto S; Arasaki A; Sunakawa H; Kinjo T
J Drug Target; 2021 Dec; 29(10):1118-1127. PubMed ID: 33979258
[TBL] [Abstract][Full Text] [Related]
5. The role of electrochemotherapy with intratumoral bleomycin for early tongue carcinoma.
Zimmermann CE; Faesser HA; Gassling V; Wiltfang J
Acta Otolaryngol; 2021 Apr; 141(4):424-431. PubMed ID: 33591860
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series.
Sturgis EM; Moore BA; Glisson BS; Kies MS; Shin DM; Byers RM
Head Neck; 2005 Sep; 27(9):748-56. PubMed ID: 16086413
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of neoadjuvant chemotherapy on metastasis of oral squamous cell carcinoma in a mouse model.
Kawashiri S; Noguchi N; Tanaka A; Nakaya H; Kato K; Yamamoto E
Oral Oncol; 2009 Sep; 45(9):794-7. PubMed ID: 19200774
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
[TBL] [Abstract][Full Text] [Related]
10. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
11. [High-dose-rate brachytherapy with local injection of bleomycin for N0 oral tongue cancer--possibilities of the control of tumor implant by inserting applicators and the decrease in tumor dose].
Ohga S; Uehara S; Miyoshi M; Jingu K
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Jan; 63(1):47-50. PubMed ID: 12645123
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological presentation of tongue cancers and early cancer treatment.
Najeeb T
J Coll Physicians Surg Pak; 2006 Mar; 16(3):179-82. PubMed ID: 16542596
[TBL] [Abstract][Full Text] [Related]
13. Expression of the cancer stem cell markers CD44v6 and ABCG2 in tongue cancer: effect of neoadjuvant chemotherapy on local recurrence.
Yanamoto S; Yamada S; Takahashi H; Naruse T; Matsushita Y; Ikeda H; Shiraishi T; Seki S; Fujita S; Ikeda T; Asahina I; Umeda M
Int J Oncol; 2014 Apr; 44(4):1153-62. PubMed ID: 24504189
[TBL] [Abstract][Full Text] [Related]
14. Electroporation therapy for T1 and T2 oral tongue cancer.
Landström FJ; Nilsson CO; Reizenstein JA; Nordqvist K; Adamsson GB; Löfgren AL
Acta Otolaryngol; 2011 Jun; 131(6):660-4. PubMed ID: 21190422
[TBL] [Abstract][Full Text] [Related]
15. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
16. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
17. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
18. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
[TBL] [Abstract][Full Text] [Related]
19. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
20. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2- locally advanced breast cancer.
Petry V; Gagliato DM; Leal AI; Arai RJ; Longo E; Andrade F; Ricci MD; Piato JR; Barroso-Sousa R; Hoff PM; Mano MS
Braz J Med Biol Res; 2015 May; 48(5):479-85. PubMed ID: 25760024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
